SCHEMBL5394841

SCHEMBL5394841

Cc1ccccc1CNC(=O)c1ccccc1-c1ccccc1C(=O)N(CCC(=O)O)Cc1ccc(F)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.48
HPGD P15428 3/20 0.48
ALDH1A1 P00352 4/20 0.45
KDM4E B2RXH2 2/20 0.45
LMNA P02545 3/20 0.43
EGFR P00533 1/20 0.43
ERBB2 P04626 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C19 P33261 1/20 0.43
KMT2A Q03164 1/20 0.43
KCNA5 P22460 2/20 0.42
KCNK3 O14649 1/20 0.42
KCNK5 O95279 1/20 0.42
KCNK17 Q96T54 1/20 0.42
KCNK9 Q9NPC2 1/20 0.42
PLA2G1B P04054 1/20 0.42
ATG4B Q9Y4P1 1/20 0.42
HDAC1 Q13547 2/20 0.42
HDAC6 Q9UBN7 2/20 0.42
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5409092 0.93 HPGD (0.53) HTTHPGDALDH1A1KDM4ELMNA
SCHEMBL5412231 0.90 KCNA5 (0.48) HTTHPGDALDH1A1LMNACYP1A2
SCHEMBL5402865 0.89 KMT2A (0.55) HTTHPGDALDH1A1KDM4ELMNA
SCHEMBL5402332 0.89 PLA2G1B (0.57) HTTHPGDALDH1A1KDM4ELMNA
SCHEMBL5397765 0.89 HDAC1 (0.49) HTTHPGDALDH1A1KDM4EKCNA5
SCHEMBL5403409 0.89 L3MBTL1 (0.47) ALDH1A1KDM4EEGFRERBB2CYP1A2
SCHEMBL5397129 0.88 HDAC1 (0.52) HTTHPGDALDH1A1KDM4ELMNA
SCHEMBL5399681 0.88 KMT2A (0.54) HTTHPGDALDH1A1KDM4ELMNA
SCHEMBL5398638 0.88 KMT2A (0.54) HTTHPGDALDH1A1KDM4ELMNA
SCHEMBL5397969 0.88 KMT2A (0.47) HTTHPGDALDH1A1LMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7285680-B2 β-alanine derivatives and the use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-10-23 US disclosed
US-20050256160-A1 Beta-alanine derivatives and the use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2005-11-17 US disclosed
EP-1533294-A1 BETA-ALANINE DERIVATIVE AND USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-05-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050256160-A1 Beta-alanine derivatives and the use thereof TGFB1, PML, APOB HTT 3791/4885HPGD 1078/4885ALDH1A1 1256/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.